ATRC vs ICUI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ATRC · AtriCure$58.54 ▼ 4.47%
ICUI · ICU Medical$172.11 ▲ 2.66%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ATRC +83.0%
- ICUI +23.6%
Head to head
| Metric | ATRC | ICUI |
|---|---|---|
| Price | $58.54 | $172.11 |
| Change today | ▼ 4.47% | ▲ 2.66% |
| Market cap | $2.98B | $4.30B |
| Return, 3 months | +40.6% | -5.7% |
| Return, year to date | +48.0% | +20.6% |
| Return, 1 year | +82.7% | +22.8% |
| P/E (TTM) | 188.8 | 72.0 |
| P/B | 5.6 | 2.0 |
| P/E percentile vs own 5y | 100th | 88th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +12.8% | +0.5% |
| Net profit growth (YoY) | +244.7% | -46.0% |
| Gross margin | 76.3% | 39.1% |
| Operating margin | 2.3% | 6.7% |
| Net margin | 1.9% | 1.4% |
| Return on equity | 2.2% | 1.4% |
| Analyst target vs. price | +5.4% | +13.6% |
| Analyst buy share | 86% | 100% |
| RSI (14) | 49 | 59 |
| 30-day volatility | 51.1% | 34.8% |
| Max drawdown, 1 year | -39.0% | -27.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ICUI is the largest of the group by market value.
- ATRC has returned the most over the past year.
- ICUI carries the lowest trailing P/E.
- ATRC is growing revenue fastest.
- ATRC keeps the most profit per dollar of sales.
- ICUI has been the calmest stock over the last 30 days.